Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: November 21, 2009
Diabetes Drug Byetta Linked to Kidney Problems
November 21, 2009The FDA has received 78 reports of kidney problems related to Byetta, a drug by Amylin Pharmaceuticals and Eli-Lilly prescribed to treat type 2 diabetes. With the new findings, the drug's label will be updated to warn doctors and patients about this possible side effect.
Byetta (exenatide) was approved in 2005. It's known as an incretin mimetic, which copies the action of incretin GLP-1, a hormone that is released in response to eating food which causes insulin to be secreted from the pancreas to lower blood glucose. The drug is injected twice a day, similar to insulin.
The drug recently was approved as a stand-alone treatment for controlling blood sugar, whereas previously it was prescribed for patients also on other diabetic therapies.
The reports of kidney failure were filed between April 2005 and October 2008. Sixty-two of the cases were for acute renal failure and 16 were cases of renal insufficiency. Most of the problems occurred in patients with pre-existing kidney disease or one or more risk factors for developing kidney problems. 91% of the patients were hospitalized, 18 required dialysis, 2 had kidney transplants, and 4 died. 80% stopped taking Byetta, and half of those patients had improvements to kidney function after discontinuing the drug.
Between 2005 and 2008, approximately 7 million prescriptions were written for Byetta. The FDA said, "Therefore, the 78 reported cases of altered renal funcion represent a small percentage of the total number of patients who have used the drug."
Some of the side effects of Byetta can contribute to kidney problems. For example, diarrhea, nausea and vomiting can lead to dehydration. Patients are encouraged to ask their physicians about their kidney function before taking Byetta and to monitor for signs and symptoms while taking the drug. Symptoms of kidney disease include changes in urine color, swelling in the feet and legs, fatigue, nausea or vomiting, and dull ache in the mid to lower back. If left untreated, kidney damage can worsen and lead to kidney failure.
Kidney malfunction may also occur as a consequence of diabetes itself, other chronic conditions, such as pancreatitis and hypertension. Concomitant use of certain medications (nonsteroidal anti-inflammatory drugs, diuretics, and antihypertensives) can also lead to kidney problems. Discontinuation of Byetta should only be considered if kidney dysfunction cannot be explained by these or other causes.
The FDA is advising physicians to avoid prescribing Byetta for patients with severe renal impairment, identified as creatinine clearance less than 30 mL per minute, or end-stage renal disease. It also recommends using caution when initiating or increasing doses from 5 micrograms to 10 micrograms in patients with moderate renal impairment. Physicians should monitor patients for the development of kidney dysfunction while on Byetta.
In 2007, Byetta was linked to a higher risk of acute pancreatitis, a potentially life-threatening inflammation of the pancreas. In October 2007 and August 2008, the FDA issued safety alerts about the reports that included cases of hemorrhagic pancreatitis and nectrotizing pancreatitis, which can be fatal. The symptoms of pancreatitis include nausea, vomiting, severe abdominal pain, a rise or fall in blood pressure, and increase heart or respiratory rates.
Adverse events for any medication should be reported to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.
Denise Reynolds RD LDN
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 8 9 [10] 11 12 13 14 15 16 17
November 17, 2009 | Consumer Reports Finds BPA in Common Canned FoodsIn the upcoming December 2009 magazine, Consumer Reports details the testing they have done on dozens of canned food products such as soups, juice, tuna fish and vegetables, for the chemical Bisphenol A, or BPA. The products tested included 19 of the most common brand names such as Campbell's, Chef Boyardee, Del ...
November 16, 2009 | Steroid Concern Prompts Bodybuilding Supplement RecallIn a press release issued November 3, 2009, Bodybuilding.com LLC, an online supplement retailer, announced that it was conducting a voluntary recall of 65 dietary supplements that were sold through the company's website. The recall is for all lots and expiration dates sold both nationwide and internationally. The FDA states they have conducted a two-year ...
November 15, 2009 | Breastfeeding Benefits Updated by the American Dietetic AssociationThe health benefits of breastfeeding for both infants and their mothers have been updated and explained in a newly released position paper by the American Dietetic Association (ADA). The ADA strongly encourages breastfeeding whenever possible, noting that it is the "optimal feeding method for the ...
Related articles:
Chronic prostatitis/chronic pelvic pain syndrome - treatment
No treatment required. It is standard practice for men with infertility and category IV prostatitis to be given a trial of antibiotics and/or anti-inflammatories however evidence for efficacy are weak. Since signs of asymptomatic prostatic inflammation may sometimes be associated with ...Section: Prostatitis
Treatment - medication (bladder instillations)
DMSO, a wood pulp extract, is the only approved bladder instillation for IC/PBS yet it is much less frequently used in urology clinics. Research studies presented at recent conferences of the American Urological Association by C. Subah Packer have demonstrated that the FDA approved dosage of a 50% solution of DMSO had the potential of creating irreversible muscle contraction. However, a lesser solution of 25% was found to be reversible. Long term use is questionable, at best, ...Section: Interstitial cystitis
Causes
The cause of IC/PBS is unknown, though several theories have been put forward (these include autoimmune, neurologic, allergic and genetic). Regardless of the origin, it is clear that the majority of IC/PBS patients struggle with a damaged urothelium, or bladder lining. When the surface glycosaminoglycan (GAG) layer is damaged (via a urinary tract infection (UTI), excessive consumption ...Section: Interstitial cystitis